How Should HIV Vaccine Efficacy Trials Be Conducted? Diverse U.S. Communities Speak Out

ISSN： 0899-9546

Source： AIDS Education and Prevention, Vol.18, Iss.6, 2006-12, pp. : 560-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generating Hypotheses to Explain Declining HIV Infection in Four U.S. Jurisdictions

AIDS Education and Prevention, Vol. 27, Iss. 1, 2015-02 ,pp. : 84-101

Guilford Publications Inc

Access to resources Recommend Favorite

Adapting a Multifaceted U.S. HIV Prevention Education Program for Girls in Ghana

AIDS Education and Prevention, Vol. 21, Iss. 1, 2009-02 ,pp. : 67-79

Guilford Publications Inc

Access to resources Recommend Favorite

Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy

By Ugen Kenneth Nyland Susan

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 281-287

Springer Publishing Company

Access to resources Recommend Favorite

HIV and AIDS in Suburban Asian and Pacific Islander Communities: Factors Influencing Self–Efficacy in HIV Risk Reduction

AIDS Education and Prevention, Vol. 18, Iss. 6, 2006-12 ,pp. : 529-545

Guilford Publications Inc

Access to resources Recommend Favorite

HIV Risk Behavior Among Amphetamine Injectors at U.S. Syringe Exchange Programs

AIDS Education and Prevention, Vol. 17, Iss. 6, 2005-12 ,pp. : 515-524

Guilford Publications Inc

Access to resources Recommend Favorite